Catherine Dunand
CEO
Works at Cemag Invest
Investor profile | Builders Republic
About
CEO of Cemag Invest in Paris, Catherine Dunand invests in Seed and Series A with a thesis focused on health and life sciences. Her track record and board mandates cover pharma (HRA Pharma, Advicenne, ONXEO), medical devices (Diabeloop, where she chaired the board from 2020 to 2023), and biotech (Metabolic Explorer, on the board from 2015 to 2019). She also sits on the board of non-health companies such as FABERNOVEL, ALTAVIA GROUP, and Kazaar. In parallel, she has been leading PROMONTOIRES since 2009 and chairs the Saul Foundation for Progress as well as Olfaktion. A graduate of an MBA from INSEAD, she has also completed training at Sciences Po and Wharton.
Profile
- Role
- CEO
- Fund
- Cemag Invest
- Nationality
- French